Presentations at the BIO Investor Forum got inside the minds of biotech investors and delivered insights into venture capital investment trends, the outlook for biotech markets, and more!Continue reading
Category Archives: Capital
Opportunity Alert: CEI Market Validtion Essentials
CEI’s Market Validation Essentials will help you build objective evidence to prove the value of your product to the consumer. Over 12 weeks, you’ll gather hard data and receive mentorship from subject matter experts to make sure there’s a place for your business to thrive in the market. This research-driven approach will help avoid trial-and-error that many new startups undergo, saving you time and money in the process.Continue reading
Time to Apply for RESI San Francisco 2017
If you are a scientist-entrepreneur or fundraising CEO starting to accumulate compelling proof-of-concept animal data or early stage clinical data, the RESI Innovation Challenge is for you.Continue reading
Opportunity Alert: NHLBI Funding and Program News
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.Continue reading
Scottsdale Cure Corridor Event Focuses on Innovation and Access to Capital
On December 4, 2015, the City of Scottsdale hosted the third annual Cure Corridor luncheon with a a focus on the life saving and life changing innovations being discovered, developed and delivered across the Scottsdale Cure Corridor and featured a keynote from NEHI’s Jonathan Fleming.Continue reading
Two new I‐Corps™ at NIH cohorts in 2016
Apply to PA-16-019 by December 10, 2016 (1st cohort) Or March 21, 2016 (2nd cohort)Continue reading
Check out the Nanotechnology Startup Challenge in Cancer
The National Cancer Institute’s (NCI) Alliance for Nanotechnology in Cancer and the Center for Advancing Innovation have partnered to create a “first of a kind” Nanotechnology Startup Challenge in Cancer or NSC2.Continue reading
